Skip to content

Quick ratio at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
3.6×-0.4×
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.1×+8.4×
Savara logo
SavaraSVRA
13.5×-1.4×
LQD
Liquidia CorporationLQDA
-0.9×
United Therapeutics logo
United TherapeuticsUTHR
4.5×-0.7×
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
1.1×-0.2×

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

Based on the most recent quarter.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's quick ratio?
Pulmonx Corporation (LUNG) reported quick ratio of 4.7× in Q1 2026.
How has Pulmonx Corporation's quick ratio changed year-over-year?
Pulmonx Corporation's quick ratio decreased by 4.3% year-over-year, from 4.9× to 4.7×.
What is the long-term trend for Pulmonx Corporation's quick ratio?
Over 5 years (2020 to 2025), Pulmonx Corporation's quick ratio has grown at a -23.9% compound annual growth rate (CAGR), from 19.1× to 4.9×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.